KR100387397B1 - - Google Patents
Info
- Publication number
- KR100387397B1 KR100387397B1 KR10-2000-0067641A KR20000067641A KR100387397B1 KR 100387397 B1 KR100387397 B1 KR 100387397B1 KR 20000067641 A KR20000067641 A KR 20000067641A KR 100387397 B1 KR100387397 B1 KR 100387397B1
- Authority
- KR
- South Korea
- Prior art keywords
- drug
- polyvinylpyrrolidone
- percutaneous
- percutaneous absorption
- weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000067641A KR20020037616A (ko) | 2000-11-15 | 2000-11-15 | 케토롤락의 경피흡수제제 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000067641A KR20020037616A (ko) | 2000-11-15 | 2000-11-15 | 케토롤락의 경피흡수제제 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020037616A KR20020037616A (ko) | 2002-05-22 |
KR100387397B1 true KR100387397B1 (ko) | 2003-06-18 |
Family
ID=19699026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020000067641A KR20020037616A (ko) | 2000-11-15 | 2000-11-15 | 케토롤락의 경피흡수제제 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20020037616A (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020050188A (ko) * | 2002-03-19 | 2002-06-26 | 에코바이오젠주식회사 | 경피흡수제로서의 용도를 위해 지용성이 부가된케토로락의 에스테르 유도체 |
KR102173192B1 (ko) * | 2020-03-11 | 2020-11-03 | 이정음 | 내구성이 향상된 패치 제조방법 |
WO2023106506A1 (ko) * | 2021-12-10 | 2023-06-15 | 주식회사 이엘와이컴퍼니 | 양친매성 고분자 점착제를 포함하는 경피 패치 제조용 하이드로겔 조성물 및 이를 이용한 경피 패치 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
KR0140155B1 (en) * | 1991-11-11 | 1998-06-01 | Hisamitsu Pharmaceutical Co | Fomentation containing ketorolac |
KR19990029891A (ko) * | 1997-09-17 | 1999-04-26 | 그루멩 쟝 마리 | 방출제어 및 서방형 경피 투여용 신규 조성물 |
KR100229815B1 (ko) * | 1997-04-18 | 1999-11-15 | 성재갑 | 테스토스테론이 함유된 경피흡수제형 및 이의 제조방법 |
KR100294084B1 (ko) * | 1998-06-02 | 2001-09-22 | 성재갑 | 비-스테로이드성소염진통제의경피흡수투여용조성물및이를포함하는경피흡수투여용제형 |
-
2000
- 2000-11-15 KR KR1020000067641A patent/KR20020037616A/ko not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
KR0140155B1 (en) * | 1991-11-11 | 1998-06-01 | Hisamitsu Pharmaceutical Co | Fomentation containing ketorolac |
KR100229815B1 (ko) * | 1997-04-18 | 1999-11-15 | 성재갑 | 테스토스테론이 함유된 경피흡수제형 및 이의 제조방법 |
KR19990029891A (ko) * | 1997-09-17 | 1999-04-26 | 그루멩 쟝 마리 | 방출제어 및 서방형 경피 투여용 신규 조성물 |
KR100294084B1 (ko) * | 1998-06-02 | 2001-09-22 | 성재갑 | 비-스테로이드성소염진통제의경피흡수투여용조성물및이를포함하는경피흡수투여용제형 |
Also Published As
Publication number | Publication date |
---|---|
KR20020037616A (ko) | 2002-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4568343A (en) | Skin permeation enhancer compositions | |
CA2153572A1 (en) | Transdermal therapeutic system with galanthamine as active ingredient | |
GR3029308T3 (en) | Medical device for the administration of active ingredients or drugs at very low doses, particularly homeopathic drugs. | |
NO20050472L (no) | Forbedret transdermalt leveringssystem for administrering av rotigotin | |
TW325406B (en) | Percutaneous absorption preparation | |
CA2255447A1 (en) | Percutaneous absorption type preparation | |
DK1418894T3 (da) | Transdermalt terapeutisk system med fentanyl | |
CA2276445A1 (en) | Transdermal hormone-delivering therapeutic system | |
KR950702811A (ko) | 프린트 경피약제투여장치(Printed Transdermal Drug Delivery Device) | |
MXPA04011214A (es) | Sistema de adminsitracion transdermica con dos capas adhesivas superpuestas que tienen afinidades diferentes por la sustancia activa incluida. | |
CA2306214A1 (en) | Plaster for topical use containing heparin and diclofenac | |
CA2251966A1 (en) | Transdermally administered dextromethorphan as antitussive agent | |
CA2387143A1 (en) | Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin | |
US6165498A (en) | Transdermal preparation containing a loratidine metabolite with antihistaminic activity | |
MY112477A (en) | Scopolamine patch | |
WO1998036740A3 (de) | Transdermales oder topisches pflastersystem mit polyacrylatmatrix mit verbesserten physikalischen eigenschaften | |
AU3551900A (en) | Desoxypeganine transdermal therapeutic system | |
AU2108300A (en) | Transdermal therapeutic system with self-adhesive matrix, containing organic acid addition salts of morphine- or morphinan-type alkaloids | |
KR100387397B1 (ko) | ||
CA2288482A1 (en) | Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis, dermatitis and dermatosis | |
DE69103459T2 (de) | Transdermale absorbierbare Eperison- oder Tolperison-Arzneizubereitung. | |
ATE214606T1 (de) | Transdermales therapeutisches system mit dem wirkstoff scopolaminbase | |
MY110391A (en) | Nitroglycerin-containing patch, a process for the production and the use thereof | |
CA2370023A1 (en) | Transdermal therapeutic system with a highly effective neuroleptic agent | |
AU2104900A (en) | Composition used as medicine and use of same for obtaining medicine for anaesthesia, in particular analgesic medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20100513 Year of fee payment: 8 |
|
LAPS | Lapse due to unpaid annual fee |